Our bodies contain over 40 trillion cells
By giving researchers tools to isolate and co-encapsulate individual cells we enable understanding of biology at an unprecedented level of detail—one cell at a time. This enables us to uncover hidden complexity that traditional bulk methods miss.
Examples of current work undertaken using this technology include:
- Reveal Cellular Heterogeneity
- Maps Development and Differentiation
- Improve Disease Understanding
- Enable Cell-Type-Specific Genomics
- Drive Biomarker Discovery
- Facilitates High-Resolution Drug Screening
Combined these have an immense impact on oncology, neuroscience and immunology.
Introducing Siora’s Single and Co-Encapsulation lab-on-chip platform.
A IP-protected proprietary platfrom to encapsulate cells and micro-entities with high precision and efficiency.
SIORA’s Microfluidic Encapsulation Platform for: Single Encapsulation and Co-Encapsulation, enables isolation of cells and micro-entities in droplets with high precision and efficiency.
Single Encapsulation
Efficiency: 63%
Frequency: 1000 droplets produced per second
Co-Encapsulation
Encapsulation Efficiency: 50%
Frequency: 2500 droplets produced per second
Explore where our technology is making an impact
Flow Cytometry
Label, sort, and analyse particles and cells with precision and speed.
Single-Cell Analysis
Isolate and study individual cells to unlock detailed biological insights.
High-Throughput Drug Screening
Run fast, consistent, small scall tests to identify promising compounds.
Encapsulation & Droplet Generation
Create uniform droplets for delivery, study, or synthesis with high efficiency.
Diagnositic Applications
Enable fast, reliable test systems with reproducible liquid handling.
Hydrogel Microbead Production
Generate uniform, biocompatible hydrogel beads for cell culture, drug delivery, or tissue engineering with scalable precision.
Meet the Team
Dr Pavel Abdulkin
CEO
Pavel is an experienced commercialization expert.Prior to SIORA Pavel was the CEO of an instrumentation company focused on R&D workflows in Advanced Therapies.
Over the course of his career, Pavel has held leadership roles in several Swiss-Based biotech companies and a director role at Deloitte where he was responsible for building a new Swiss R&D business unit.
Richard Gray
Chairman of the board
Engineer and Entrepreneur with wide experience in managing fast-track product and process design and development, and managing, motivating, and developing the people needed to make it happen.
Experience at General Manager level with P&L responsibility for a 150-person business in pharma instrumentation sector. Experience of acquisitions, disposals, and new ventures including founding, growing and selling high technology businesses.
Dr Anoshanth Jeyasountharan
Head of Technology and Applications
Ano earned his PhD from Swansea University in 2022. He began his career with internships at leading financial institutions and worked as a consultant at Amazon’s centralised consultancy unit before joining a boutique financial consultancy firm.
In 2024, he returned to academia to pursue postgraduate research, where he developed cutting-edge microfluidic (lab-on-chip) technology for biotechnology applications. This research led to the co-founding of Siora Ltd in 2025 and Ano is the head of technology and applications at Siora, leading the development and delivery of cutting-edge innovations.
Dr Francesco Del Giudice
Non-executive Scientific Advisory Board Member
Francesco Del Giudice, PhD, CEng CSci MIChemE, MInstP, FHEA is an associate professor of the Complex Fluids Research Groups in the Department of Chemical Engineering at Swansea University.
Francesco’s research interest focusses on bringing together complex fluids and microfluidics to develop the next generation of diagnostic platforms. Francesco is the co-founder of Siora ltd.
Dr Claire Barnes
Non-executive Scientific Advisor
Claire Barnes earned her PhD from Swansea University in 2018, focusing on activity data analytics. She developed expertise in AI and machine learning through postdoctoral research on single-cell analytics and image flow cytometry. In 2020, she conducted research at the Broad Institute, creating open-source deep learning tools.
Now a lecturer in biomedical science at Swansea, her work applies AI to human-centred data. In 2025, she joined Siora Ltd’s scientific advisory board to support AI integration in microfluidic systems.
Get in Touch
Ready to advance your research with precision tools? Contact us to learn more about our platform.